| ACT | Activated clotting time |
| ADP | Adenosine diphosphate |
| AHA | Acquired haemophilia A |
| aPTT | Activated partial thromboplastin time |
| AUC | Area under the curve |
| AvWS | Acquired von Willebrand syndrome |
| BU | Bethesda unit |
| CEM | Clot elastic modulus |
| CHAMP | CDC Hemophilia A Mutation Project |
| CHBMP | CDC Hemophilia B Mutation Project |
| CR | Clot rate |
| DIC | Disseminated intravascular coagulation |
| dRVVT | Diluted Russell viper venom time |
| dNTPs | Deoxyribonucleotide triphosphates |
| ddNTPs | Dideoxynucleotides |
| ED | Exposure day |
| ELISA | Enzyme-linked immunosorbent assay |
| ETP | Endogenous thrombin potential |
| F | Factor |
| FDA | Food and Drug Administration |
| FIIa | Activated FII |
| FIX CD | FIX congenital deficiency |
| FV | FV congenital deficiency |
| FVII CD | FVII congenital deficiency |
| FVIII CD | FVIII congenital deficiency |
| FX CD | FX congenital deficiency |
| FXI CD | FXI congenital deficiency |
| FXII CD | FXII congenital deficiency |
| FXIII-A | FXIII subunit A |
| FXIII-B | FXIII subunit B |
| FXIII CD | FXIII congenital deficiency |
| GIDH | Glutamate dehydrogenase |
| GP | Glycoprotein |
| GT | Glanzmann's thrombasthenia |
| HA | Haemophilia A |
| HB | Haemophilia B |
| HEPES | 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid |
| HIS | Heparin Insensitive |
| HIV | Human immunodeficiency virus |
| HLA | Human leucocyte antigen |
| HRP | Horseradish peroxidase |
| HMWK | High molecular weight kininogen |
| HwI | Haemophilia with inhibitors |
| Ig | Immunoglobulins |
| INR | International normalised ratio |
| ISI | International sensitivity index |
| ISTH | International Society on Thrombosis and Haemostasis |
| ITGA2B | Integrin subunit alpha 2b |
| ITGB3 | Integrin subunit beta 3 |
| K | Clot formation time |
| KCT | Kaolin clotting time |
| LA | Lupus anticoagulant |
| LTA | Light transmission aggregometry |
| MA | Maximal clot firmness |
| MASAC | Medical and Scientific Advisory Council |
| MNPT | Mean normal prothrombin time |
| NADPH | Nicotinamide adenine dinucleotide phosphate |
| PA | Peak amplitude |
| PCR | Polymerase chain reaction |
| PCF | Platelet contractile force |
| PF3 | Platelet factor 3 |
| PFA | Platelet function analysis |
| PIVKA | Protein induced by vitamin K absence/antagonist-II |
| PK | Plasma kallikrein |
| PLPs | Phospholipids |
| pNA | para-nitroaniline |
| PNP | Platelet neutralisation procedure |
| PPP | Platelet-poor plasma |
| PRP | Platelet-rich plasma |
| PT | Prothrombin time |
| R | Clotting time |
| Rco | Ristocetin cofactor |
| ROTEG | Rotational thromboelastography |
| ROTEM | Rotational thromboelastometry |
| RTF | Recombinant tissue factor |
| RUO | Research use only |
| RVV | Russel viper venom |
| RVVT | Russel viper venom time |
| SCT | Sonoclot analysis |
| SCT | Silica clotting time |
| TAFI | Thrombin-activatable Fibrinolysis inhibitor |
| sTF | Soluble tissue factor |
| TF | Tissue factor |
| TFPI | Tissue factor pathway inhibitor |
| TEG | Thromboelastography |
| TEM | Thromboelastometry |
| TGA | Thrombin generation assay |
| TGT | Thrombin generation time |
| TRAP | Thrombin receptor activating peptide |
| vW | von Willebrand |
| vWD | von Willebrand disease |
| vWF | von Willebrand factor |
| WFH | World Federation of Hemophilia |
| WHO | World Health Organisation |
